CD82 and posterior cortical atrophy: For primary PCa, CD82 might represent both an early diagnostic and a prognostic marker because its expression is inversely correlated with GS (being absent in patients with GS ≥ 7), and the stratification of PCa patients based on CD82 expression in blood CTCs allowed the identification of patients with reduced survival and a higher risk of biochemical recurrence [30].